In inflammatory bowel disease (IBD), this shift reduces colonic inflammation (Saadh et al., 2023) and promotes mucosal healing, as evidenced by decreased TNF-α and increased IL-10 levels in murine colitis models (Jung et al., 2015). The gene discussed is IL10; the disease is colitis.